Module 01 · ADMET Prediction · Now building

The intelligence layer
for drug discovery

ML-powered ADMET predictions, explainable at the atom level. Catch toxicity signals early — before they cost you a clinical trial.

औषध Aushadh medicine · drug
+
वेद Veda knowledge · wisdom
=
Aushved knowledge of medicine
Module 01 · In Development

ADMET Prediction

Predict absorption, distribution, metabolism, excretion and toxicity from a SMILES string in under 1.5 seconds — with atom-level explanations so you know why, not just what.

hERG Cardiotoxicity

Binary classifier trained on TDC canonical splits (AUROC >0.84). Flags compounds that risk QT prolongation before they reach wet-lab assays.

Gate 1 · Q1 2027

DILI & Ames

Drug-induced liver injury and genotoxicity screening. Same API endpoint, same sub-second latency, same atom-level explainability.

Gate 1 · Q1 2027

SHAP Atom Maps

GradientExplainer identifies exactly which atoms drive each prediction, rendered as a 2D SVG heat map on the molecular structure.

Gate 1 · Q1 2027
Why Aushved

Built by practitioners,
for practitioners

Sub-second predictions

ONNX-optimised inference on Cloud Run. Single molecule in <1.5 s, batch of 1,000 in under a minute.

Atom-level explainability

SHAP GradientExplainer shows which atoms drive each prediction. Defensible to medicinal chemists and regulatory reviewers.

API-first design

REST API with OpenAPI spec, JWT + API key auth, async batch jobs and audit logs. Built for enterprise IT security review.

State-of-the-art models

Chemprop v2 DMPNN — consistently top-ranked on TDC ADMET benchmarks. Not a wrapper around a public API.

Full data lineage

Every prediction traces back to training dataset, model version and AUROC. Complete reproducibility for regulatory dossiers.

12+ years pharma depth

Built by someone who has worked inside Genentech, Novartis, Celgene and Novo Nordisk — not just read the papers.

Early Access

Be first when we launch

ADMET predictions for your pipeline, Q1 2027. First 50 sign-ups get a free 90-day trial at launch.

✓ You're on the list. We'll reach out before launch.